Therefore, we performed an immunohistochemistry-based evaluation of EZH2 expression in normal breast tissue in women with biopsy-confirmed benign breast disease (BBD) in the Nurses’ Health Studies and examined the association between EZH2 expression and subsequent breast cancer risk. The gene discussed is EZH2; the disease is breast fibrocystic disease.